Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Mar 23, 2018
Document Date
Mar 16, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
NOVARTIS AG